Yabao Pharmaceutical announced that revenue for the first half of 2026 was 1,145 billion yuan, an increase of 0.49% over the previous year. Net profit attributable to shareholders of listed companies was 178 million yuan, an increase of 1.83% over the previous year. After deducting non-net profit of 179 million yuan, a year-on-year increase of 12.28%. The company's 2026 mid-term profit distribution plan is to pay a cash dividend of 2 yuan for every 10 shares.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.